TL;DR: Cross-border clinician access under MyHealth@EU is moving toward eIDAS high assurance by March 2032, with stronger identity proofing and lifecycle controls becoming the real test, according to Crayonic. Hospitals will need hardware-backed credentials, auditable issuance, and prompt revocation to avoid a second migration.
Editorial analysis by NHI Mgmt Group, based on content published by Crayonic: “From 2032, clinicians reaching across EU borders must sign in at eIDAS “high””.
By the numbers:
- From 26 March 2032 clinicians using MyHealth@EU must reach the assurance level high under eIDAS.
- The regulation applies generally from 26 March 2027.
Key questions
Q: Why do hardware-backed credentials matter more than MFA for regulated clinical access?
A: Hardware-backed credentials matter because they make the private key difficult to copy, share, or replay from a compromised workstation.
Q: What breaks when clinician identity proofing and revocation are weak?
A: Weak proofing and revocation break the assurance chain, even when login technology looks strong.
Q: How should hospitals prepare clinician authentication for eIDAS high assurance?
A: Hospitals should treat eIDAS high as an end-to-end identity programme, not a password upgrade.
Practitioner guidance
- Define an assurance-level inventory Map every clinician sign-in path to the assurance level it can actually demonstrate today, including where proofing, authentication, and revocation evidence lives.
- Remove copyable second factors from clinical access Replace shared or software-only credentials with non-exportable credentials for access paths that must survive a high-assurance audit.
- Bind credential issuance to identity proofing records Ensure the identity provider can show who was enrolled, what evidence was used, and when the credential was issued and revoked.
Bottom line: The article reframes cross-border clinical access as an identity assurance issue, with eIDAS high becoming the relevant benchmark by 2032.
Glossary terms: eIDAS Level of Assurance, Identity proofing, Hardware-Based Authentication, LifeCycle Revocation
Explore further
View Full Forum → | NHI Foundation Course → | Our Services → | Read the full analysis →
eIDAS high turns clinician identity into a regulated assurance problem, not a local authentication preference. The article shows that hospitals will not be able to treat cross-border access as an edge case because the same login method is likely to become the default clinical workstation standard. That collapses the old assumption that access methods can vary by workflow, and it makes assurance evidence part of the identity operating model. Practitioners should treat the deadline as an architecture decision, not a policy memo.
A few things that frame the scale:
- 92% of organisations expose NHIs to third parties, raising concerns about supply chain security, according to the Ultimate Guide to NHIs.
A question worth separating out:
Q: What is the difference between eIDAS substantial and high assurance for healthcare access?
A: Substantial requires at least two authentication factors from different categories under the person’s control. High goes further by requiring resistance to duplication and tampering, and protection against capable attackers. For healthcare access, that difference usually pushes organisations away from copyable credentials and toward hardware-rooted possession with tighter identity governance.
👉 Read our full editorial: eidas high assurance resets clinician identity for cross-border care